SomnoMed
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - non WASomnoMed Limited (SOM) provides diagnostic and treatment solutions for sleep-related breathing disorders including obstructive sleep apnea, snoring and bruxism.
It produces and sells devices primarily in the Asia Pacific region, North America and Europe.
Lists and Charts
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 30/09/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1190th | SomnoMed | -27% | -23% |
1743 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | SomnoMed | $91.8m |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| NEW ROLE: Marco Kleef, | 11 Nov 2022 |
| NEW ROLE: Karen Borg, Non-Executive Director | 24 Dec 2020 |
| NEW ROLE: Derek Smith, Chief Executive Officer | 24 Nov 2020 |
| NEW ROLE: Herv Fivet, Chief Financial Officer | 24 Nov 2020 |
| NEW ROLE: Jim Evanger, Chief Executive Officer of Sleep Centres America | 24 Nov 2020 |
| NEW ROLE: HervE FiEvet, | 24 Nov 2020 |
| NEW ROLE: Mark Harding, | 24 Nov 2020 |
| NEW ROLE: Matthew Conlon, | 24 Nov 2020 |
| NEW ROLE: Martin Weiland, VP:Sales & Marketing Europe | 24 Nov 2020 |
